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Abstract
Background: Biological effects of nuclear factor-κB (NFκB) can differ tremendously depending on the
cellular context. For example, NFκB induced by interleukin-1 (IL-1) is converted from an inhibitor of death
receptor induced apoptosis into a promoter of ultraviolet-B radiation (UVB)-induced apoptosis. This
conversion requires prolonged NFκB activation and is facilitated by IL-1 + UVB-induced abrogation of the
negative feedback loop for NFκB, involving a lack of inhibitor of κB (IκBα) protein reappearance.
Permanent activation of the upstream kinase IKKβ results from UVB-induced inhibition of the catalytic
subunit of Ser-Thr phosphatase PP2A (PP2Ac), leading to immediate phosphorylation and degradation of
newly synthesized IκBα.
Results: To investigate the mechanism underlying the general PP2A-mediated tuning of IKKβ
phosphorylation upon IL-1 stimulation, we have developed a strictly reduced mathematical model based
on ordinary differential equations which includes the essential processes concerning the IL-1 receptor,
IKKβ and PP2A. Combining experimental and modelling approaches we demonstrate that constitutively
active, but not post-stimulation activated PP2A, tunes out IKKβ phosphorylation thus allowing for IκBα
resynthesis in response to IL-1. Identifiability analysis and determination of confidence intervals reveal that
the model allows reliable predictions regarding the dynamics of PP2A deactivation and IKKβ
phosphorylation. Additionally, scenario analysis is used to scrutinize several hypotheses regarding the
mode of UVB-induced PP2Ac inhibition. The model suggests that down regulation of PP2Ac activity, which
results in prevention of IκBα reappearance, is not a direct UVB action but requires instrumentality.
Conclusion: The model developed here can be used as a reliable building block of larger NFκB models
and offers comprehensive simplification potential for future modeling of NFκB signaling. It gives more
insight into the newly discovered mechanisms for IKK deactivation and allows for substantiated predictions
and investigation of different hypotheses. The evidence of constitutive activity of PP2Ac at the IKK
complex provides new insights into the feedback regulation of NFκB, which is crucial for the development
of new anti-cancer strategies.
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Nuclear factor κB (NFκB) (p65/p50) is a transcription fac-
tor of central importance in inflammation and anti-apop-
totic signaling [1]. Since constitutive activation of NFκB
was shown to contribute to the maintenance of a range of
cancers by inducing expression of anti-apoptotic genes [2-
4], manifold approaches were made to develop new anti-
cancer strategies based on NFκB inhibition [3,5]. Canoni-
cal activation of NFκB by the pro-inflammatory cytokine
interleukin-1 (IL-1) requires activation of the inhibitor of
κB (IκBα) kinase complex (IKK), especially phosphoryla-
tion of the catalytic subunit IKKβ at Ser 177/181 [6]. Phos-
phorylated IKKβ consequently phosphorylates IκBα at Ser
32/36, leading to its poly-ubiquitination and proteasomal
degradation. Liberated NFκB translocates into the nucleus
to activate transcription of responsive genes [6]. Accord-
ingly, co-stimulation of cells with IL-1 was shown to
inhibit death ligand-induced apoptosis via up-regulation
of anti-apoptotic genes and their products [7,8]. In con-
trast, ultraviolet-B radiation (UVB)-induced apoptosis
was not inhibited but significantly enhanced upon co-
stimulation with IL-1. This process on the one hand was
associated with NFκB-dependent repression of anti-apop-
totic genes. On the other hand, it coincided with long
term transcriptional up-regulation followed by pro-
nounced release of tumor necrosis factor α(TNFα), which
activates the death receptor TNF-R1 in an autocrine fash-
ion, thereby enhancing UVB-induced apoptosis [9]. Both
effects were shown to be NFκB dependent, indicating that
UVB is capable to persistently convert NFκB function
from an inhibitor into a promoter of apoptosis. This
newly-discovered UVB-mediated pro-apoptotic activity of
NFκB appears of utmost importance, because it challenges
the dogma of NFκB inhibition as a general approach to
fight cancer. In contrast, the new evidence provides a basis
for alternative approaches in cancer therapy combining
induction of DNA damage with NFκB activation rather
than inhibition. It is therefore of prime interest to unravel
the detailed mechanisms underlying this complex feed
back regulation of the NFκB system.
In order to fully convert the cellular NFκB response from
anti- to pro-apoptotic functions, transient NFκB activa-
tion appears to be insufficient. In fact, recent data revealed
a prolonged IL-1-induced nuclear activity of NFκB in epi-
thelial cells co-treated with UVB to be responsible for
switching the cellular response towards a pro-apoptotic
phenotype [10]. It is generally accepted that activation of
NFκB triggers transcription of IκBα, thereby inducing
resynthesis of its inhibitor in a negative regulatory feed-
back loop [11]. This negative feedback loop was shown to
be completely abrogated in cells co-treated with IL-1 and
UVB, caused by immediate phosphorylation and proteas-
omal degradation of the newly synthesized protein[10].
Instant phosphorylation of resynthesized IκBα was facili-
tated by continuously activated IKKβ. Chronic Ser 177/
181 phosphorylation of IKKβ was due to UVB-induced
inhibition of the catalytic subunit of the Ser-Thr phos-
phatase PP2A (PP2Ac) [10]. As a consequence, active
NFκB persists in the nucleus for several hours providing
sufficient time to fundamentally change the transcrip-
tional program and physiologic response of the cell.
The exact molecular mechanisms and kinetics, however,
underlying PP2A-mediated IKKβ dephosphorylation in
response to IL-1 as well as UVB-induced PP2A inhibition
remain to be determined. Either constitutively active or
signal activated PP2A may modulate IKKβ activity. To
identify the responsible mode of action we developed a
mathematical model of IKKβ phosphorylation based on
experimental data.
Several models describing NFκB activation following IKK
phosphorylation have been published to date [12], most
of them based on the seminal model of Hoffmann et al.
[13]. Since these models mainly focus on IκB/NFκB kinet-
ics, they often do not explicitly describe receptor kinetics.
A problem of these generally large models, which is often
exacerbated by a comparatively sparse experimental data
basis, is that parameters are frequently functionally
related and can therefore not be determined unambigu-
ously: the parameters are not identifiable [14]. Particu-
larly, the amount of additional parameters and the system
complexity increase tremendously when the IκB/NFκB
part of the model influences IKK or when the signaling
cascade is extensively modeled. For example, studies of
Cho et al. [15] and Park et al. [16] presented very detailed
models of TNF-mediated signaling upstream of IκBα,
including receptor kinetics and IKK activation. While this
approach is very valuable for theoretical studies, the esti-
mation of reliable parameter values would require a huge
amount of experimental data. Consequently, Werner et al.
[17] did not fit their model to IKK activity data but rather
used these data as an input for the IκB/NFκB module.
Cheong et al. [18] assessed the problem in a more mathe-
matical way and modeled IKK kinetics by activation and
deactivation functions without direct biological counter-
part. Those approaches avoid most identifiability prob-
lems, but do not provide an insight into the activation and
deactivation processes of IKK. A model for IL-1 receptor
signaling exemplifying the identifiability issue has been
proposed recently, but lacks experimental validation [19].
In sum, existing models contribute to a deeper under-
standing of the phosphorylation dynamics of IKKβ, but
an experimentally validated model for IL-1 signaling with
fully identifiable parameters including the essential bio-
logical processes has not been devised to date.
Focusing on IKKβ phosphorylation following IL-1 stimu-
lation, we present a model with pronounced modularityPage 2 of 13
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parts of it. The individual modules are not connected by
mass flows, but by unidirectional signal flows, and can
therefore also be considered decoupled from the remain-
ing model. Particular attention is paid to a careful simpli-
fication resulting in a very good identifiability of the
parameters. We use a combination of modeling and
experimental methods to analyze the system behavior,
and provide evidence that constitutively active PP2A con-
tinuously dephosphorylates IKKβ, thereby sustaining the
negative feedback loop for NFκB and maintaining proper
cellular function.
Results
UVB inhibits IκBα reappearance via continuous 
phosphorylation of IKKβ
Initiation of transient NFκB activation upon IL-1 stimula-
tion (10 ng/ml) requires Ser177/181 phosphorylation of
IKKβ. Subsequent IκBα phosphorylation and proteaso-
mal degradation is completed at the latest after 15 min.
Reappearance of IκBα after 90 min perfectly matches
dephosphorylation of IKKβ and disappearance of NFκB
from the nucleus (Figure 1). Costimulation with UVB,
however, results in complete inhibition of IκBα reappear-
ance and NFκB termination. Under these conditions the
phosphorylation status of IKKβ is somewhat lowered after
90 min but still remains at elevated levels over hours,
ensuring continuous phosphorylation and degradation of
gradually upcoming levels of resynthesized IκBα
(Figure 1).
The activation status of PP2A at the IKK complex
PP2A is a ubiquitously expressed Ser/Thr phosphatase
which is involved in a wide range of cellular processes,
only a very small fraction being responsible for IKKβ reg-
ulation, meaning that overall measured PP2A activity may
differ from the specific local activation status. In general,
two mechanisms of PP2A activity may explain the
observed phosphorylation status of IKKβ (Figure 2A).
Either inactive PP2A is recruited to the IKK complex in
unstimulated cells and becomes activated with a certain
delay following IL-1 treatment. Activated PP2A then ter-
minates IKKβ activity, thereby allowing for stabilization
of resynthesized IκBα. Alternatively, a constitutively low
level of activated PP2A continuously counteracts the IKKβ
phosphorylation and thus activity state (Figure 2A). Previ-
ous data from our lab revealed PP2Ac to be constitutively
recruited to IKKβ, even in unstimulated cells [10]. Here,
Failure of IκBα reappearance coincides with continuous IKKβ phosphorylation and NFκB activationig re 1
Failure of IκBα reappearance coincides with continuous IKKβ phosphorylation and NFκB activation. KB cells 
were left untreated or stimulated with 10 ng/ml IL-1 alone or in combination with UVB (300 J/m2). At the indicated time points 
cytosolic as well as nuclear protein extracts were generated. Cytosolic extracts were analysed for the phosphorylation status 
of IKKβ and IκBα degradation by Western-blotting. Equal loading was monitored with an antibody against α-tubulin. In parallel, 
nuclear translocation of NFκB was determined by EMSA with an NFκB specific oligonucleotide. Data shown represent one out 
of three independently performed experiments.
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Hypotheses of PP2A activityFigure 2
Hypotheses of PP2A activity. (A) The IKK phosphorylation curve consists of two phases. Phase I is defined by an increase 
of phosphorylated IKK, indicating a predominant kinase activity. Phosphorylated IKK decreases in phase II, indicating a predom-
inant phosphatase activity. Both activation of PP2A by IL-1 and constitutive PP2A activity could explain this behaviour. Scaling is 
different for PP2A and the IKK kinase. (B) Cells were left untreated or were stimulated with IL-1 for 15 min and 2 h respec-
tively. Subsequently, PP2Ac was immunoprecipitated and subjected to an in vitro phosphatase assay using a threonine-phos-
phopeptide as a substrate. Pooled data of three independently performed experiments are depicted. (C) Cells were pre-
stimulated or not with 20 μM MG132 for 1 h. Subsequently cells were left untreated or stimulated with IL-1 for 15 min or 2 h. 
Phosphorylation status of IKKβ and protein status of IκBα were determined by Western-blot analysis using α-tubulin as load-
ing control.
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min of IL-1 treatment, reflecting initial IκBα degradation,
and after 2 h, representing the time point of full IκBα
resynthesis (see Figure 1). Phosphatase activity assay did
not reveal any significant changes in overall cellular
PP2Ac activity at the different time points measured (Fig-
ure 2B), allowing to assume that PP2A located at the IKK
complex might also be constitutively active. In order to
investigate whether this assumption is consistent with the
observed IKKβ phosphorylation pattern and because
PP2Ac amounts recruited to IKK are too small to be relia-
bly analyzed separately, we designed an ordinary differen-
tial equation model resuming the essential processes
based on the assumption of constitutive PP2A activity.
However, to rule out that PP2A may additionally target
IκBα directly for dephosphorylation, phosphorylated
IκBα was captured by addition of the proteasome inhibi-
tor MG132. 15 min after IL-1 stimulation, IKK is strongly
phosphorylated and IκBα disappeared due to proteaso-
mal degradation. Addition of MG132 consequently
resulted in appearance of non-degradable, phosphor-
ylated IκBα, evident from the shifted IκBα band (Figure
2C). Two hours later, IKKβ was completely dephosphor-
ylated and IκBα reappeared as described before. Upon
proteasome inhibition IκBα stayed phosphorylated over
the observed time period, indicating that PP2A primarily
targeted IKKβ and not IκBα, the latter, if at all, with a sig-
nificantly slower kinetics (Figure 2C).
IKK phosphorylation following IL-1 stimulation can be 
modeled decoupled from the downstream processes
Our model is based on the following biochemical reac-
tions:
where ILRc and ILR represent the IL-1 receptor with and
without bound IL-1, respectively, IKKp and IKK denote
phosphorylated and unphosphorylated IKKβ, respec-
tively, and PP2A reflects active PP2Ac at the IKK complex.
The model structure is shown in Figure 3A. The significa-
tion of the model parameters is depicted in Table 1.
These reactions imply that IKK phosphorylation can be
considered independently of the downstream processes.
In contrast, the vast majority of mathematical models for
NFκB signaling pathways are based on the one by Hoff-
mann et al. [13], representing phosphorylation of IκBα as
transient complexing of phosphorylated IKK with IκBα,
where only uncomplexed IKK can be deactivated. In these
models, IKK phosphorylation kinetics can therefore not
be considered independently of the IκBα/NFκB kinetics.
However, complexing of IKK with IκBα can also be
approximated as a catalytic influence of IKK on IκBα,
using the quasi-steady-state approximation [20] for all
complexes involving IKK. Considering the model by Lip-
niacki et al. [21], it can be shown that the behavior of the
reduced model is almost identical to the kinetics of the
original one (Additional file 1, I). This finding offers a sig-
nificant simplification potential for future modeling of
NFκB signaling. Since the further coupling of IKKβ and
NFκB via the A20 feedback only exists for TNFα induced
NFκB signaling [22], but has been shown to be negligible
for IL-1 induced NFκB signaling [23], we can consider
IKKβ kinetics independently of the downstream processes
involving NFκB.
Assuming mass action kinetics, an initially completely
uncomplexed receptor, initially unphosphorylated IKK
and constitutively active PP2A, the system can now be
written in terms of differential equations as follows:
ILR ILRc
IKK IKKp
IKKp
ka il ki
kp ILRc
kdp PP2A
⋅
⋅
⋅
⎯ →⎯⎯ ⎯ →⎯⎯
⎯ →⎯⎯⎯
⎯ →⎯⎯⎯⎯
⎯ →⎯⎯⎯⋅
IKK
PP2A uv kuv
d ILR(t)
dt
ka il(t) ILR(t), ILR(0) 1
d ILRc(t)
dt
ka il(t)
= − ⋅ ⋅ =
= ⋅ ⋅ ILR(t) ki ILRc(t), ILRc(0) 0
d IKKp(t)
dt
kp ILRc(t) IKK(t)
− ⋅ =
= ⋅ ⋅ − ⋅ ⋅ =
= − ⋅ ⋅
kdp PP2A(t) IKKp(t), IKKp(0) 0
d PP2A(t)
dt
kuv uv(t) PP2A(t), PP2A(0) 1
with IKK (t) = 1  IKKp(t).
=
−
Table 1: Model parameters in the reference scenario
Variable Process Value Unit
ka association of IL-1 to the receptor 6.7 (μM·s)-1
ki internalization of the receptor complex 0.0034 s-1
kp phosphorylation of IKK 0.095 s-1
kdp dephosphorylation of IKKp 0.00076 s-1
kuv deactivation of PP2A under UVB 0.00024 s-1
IKKscale scaling of the model to the data 0.96 -
Note that the unit μM occurs only in the reaction involving IL-1, since all state variables are dimensionless and can be interpreted as fraction of the 
total initial protein.Page 5 of 13
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for t < 0, and 0.000588 μM for t ≥ 0, corresponding to the
experimentally applied dose of 10 ng/ml. With 300 J/m2
UVB stimulation, uv(t) is the Heaviside function, uv(t) = 0
for t < 0, and uv(t) = 1 for t ≥ 0. Consequently, without
UVB stimulation uv(t) ≡ 0. The model was scaled to the
experimental data using a unique scaling factor for all IKK
observations. An upper bound of 0.095 s-1 was imposed
on kp, based on biophysical considerations (see Addi-
tional file 1, II). No bounds were assumed for the remain-
ing parameters.
The hypothesis of constitutive PP2A activity is consistent 
with the experimental data
The model assuming constitutive PP2A activity (Figure
3A) was fitted to the experimentally determined IKKβ
phosphorylation pattern following stimulation with IL-1
(10 ng/ml), with or without UVB co-stimulation. The sim-
Schematic representation and simulation results of the mathematical model of the activation status of PP2Ac at the IKK com-plexFigure 3
Schematic representation and simulation results of the mathematical model of the activation status of PP2Ac 
at the IKK complex. (A) The IL-1 receptor and IL-1 form the IL-1 receptor complex which triggers IKKβ phosphorylation. 
PP2Ac dephosphorylates phosphorylated IKKβ and is deactivated by UVB radiation. Ellipses denote model inputs, boxes with 
solid lines denote state variables, and boxes with dotted lines denote species whose concentration can be calculated from the 
state variables by mass conservation relations. Normal arrows denote mass flows following mass action kinetics, circles at the 
arrow tail signify that the involved species participates catalytically in the reaction (signal flow). (B) The model assuming consti-
tutive PP2Ac activity matches the experimental data calculated from Figure 1 well (χ2 = 10.46 + 13.99 = 24.45). Experimental 
data are shown as mean and standard deviation of three independently performed experiments.
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well (χ2 = 10.46 + 13.99 = 24.45; Figure 3B and Table 1),
particularly when considering the relatively small system
order. In the following, this model structure with these
parameters is referred to as the reference scenario. Com-
pared to experimental data, peak concentrations are
reached much more rapidly in the simulation than in the
experimental data. This effect can be attributed to the
choice of the objective function rather than to limitations
induced by the model structure: since the standard devia-
tions are higher during the first 30 minutes, higher devia-
tions are tolerated in this time interval. Indeed, a visually
more satisfactory fit with peak concentrations shortly after
15 minutes is possible with a slightly larger χ2 value
(28.09, see Additional file 2) and very similar values for
ka, ki, kuv and kdp. Results presented show that constitu-
tive PP2A activity is indeed consistent with the observed
IKKβ phosphorylation pattern.
A similar model developed for investigating the alterna-
tive hypothesis of initially inactive PP2Ac, however,
yielded comparable results (see Additional file 3), so that
none of the two possible mechanisms can be excluded
based on modeling results. Consequently, experimental
data are consistent with the principle of either hypothesis.
Experimental data substantiate the constitutive activity of 
PP2A
To finally address the activation status of PP2Ac and its
impact on initial IKKβ phosphorylation we performed
PP2Ac knock-down experiments. As a prerequisite, a sen-
sitive IL-1 dose had to be determined allowing observa-
tion of minor changes in IκBα levels and IKKβ
phosphorylation. Performing dose-response experiments
ranging from 10 ng/ml to 0.1 ng/ml IL-1 for 15 min
revealed 0.5 ng/ml to be the sensitive dose of choice upon
which initial IκBα degradation has only partially taken
place (Figure 4A). Using this sensitive dose of 0.5 ng/ml
IL-1, delayed IKKβ phosphorylation was observed com-
pared to treatment with 10 ng/ml (compare Figure 1 and
Figure 4B). Investigating very short sampling intervals
finally disclosed IKKβ phosphorylation to start very early
1 min after IL-1 treatment (Figure 4B and 4C). However,
when PP2Ac was knocked down by siRNA, very early
phosphorylation of IKKβ was enhanced, being most pro-
nounced after 30 min of treatment (Figure 4C; for one
representative Western Blot see Additional file 4). These
data clearly indicate PP2A to be constitutively active when
located at the IKK complex. Furthermore, the model dem-
onstrates that no additional mechanism is required to
explain the experimental data.
The model parameters are very well identifiable
In order to determine whether the estimated parameter
values are unique, we conducted an identifiability analy-
sis as described in the Methods section. The χ2 value of the
best 10% of the fits was consistently 24.45. The distribu-
tion of the parameter values clearly shows that the param-
eters can be uniquely determined for the given
observations within the very large investigated parameter
range, as the variance in the parameter sets yielding the
best χ2 values is extremely low (Figure 5A). The parameter
kp thereby attains its upper bound, so that the upper
bound estimate affects the parameter identification. How-
ever, all parameters except kp itself are robust against var-
iations of the upper bound in a range of at least two orders
of magnitude (see Additional file 1).
When considering the influence of noise in the experi-
mental data, the parameter values still remain meaning-
ful: the lower and upper bounds of the 95% confidence
intervals do not vary by more than a factor of 2 for any of
the parameters (Table 2). Consequently, the determined
parameter values allow for some predictions concerning
the occurring processes: Firstly, the model parameters sug-
gest that internalization of the receptor complex occurs
within a few minutes. Furthermore, a fast association of
IL-1 to the receptor is predicted, which is confirmed by lit-
erature data [24] (see also Additional file 1, III).
The model rejects the hypothesis of immediate complete 
PP2A deactivation
Finally, the model also makes predictions about the mode
of PP2A deactivation. Direct deactivation of PP2Ac by
UVB radiation (e.g. by destroying the active centre) would
be expected to occur almost immediately. Since a rela-
tively slow decrease of PP2A activity (t½ = ln2/kuv = 48
min) is predicted, the model suggests an indirect and
gradual effect of UVB on PP2Ac. In order to exclude the
possibility of an immediate deactivation of PP2Ac in the
model, we tested the special case kuv→∞ (or equivalently
kdp = 0 for UVB radiation). The resulting fits clearly show
that the model cannot match the experimental data if we
assume immediate PP2A deactivation (Figure 5B). This
indicates that UVB-induced gradual PP2Ac inactivation is
an indirect effect that requires instrumentality by other
molecules.
IL-1 receptor internalization is fast and unaffected by UVB 
radiation
IL-1-induced NFκB activation is terminated by IL-1 recep-
tor (IL-1R) internalization, thereby limiting the duration
of the exogenous input [25]. Although our data strongly
indicate PP2Ac to be constitutively active at the IKK com-
plex regulating the phospho-IKKβ turn over, prolonged
IL-1 receptor (IL-1R) activation by UVB may alternatively
influence the phospho-IKK status. To investigate whether
UVB interferes with the kinetics of IL-1R internalization,
and to validate the model prediction of fast internaliza-
tion, FACS analysis was performed. Comparing cellsPage 7 of 13
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1R internalization to follow almost identical kinetics,
starting very early after 5 min and being completed latest
after 60 min (Figure 6A), indicating changes of IL-1R
internalization to be irresponsible for prolonged IKKβ
phosphorylation. Since the high standard deviation
between the independently performed experiments did
not allow for a definitive rejection of the hypothesis, we
additionally used the model to scrutinize this hypothesis:
We altered the model by assuming that UVB radiation
does not affect IKKβ dephosphorylation, but alters the
internalization of IL-1R (for model equations see Addi-
tional file 1, IV). The resulting fits (Figure 6B) are consid-
erably worse (χ2 = 24.77 + 25.35 = 50.12) than those of
the original model, so that the model suggests rejection of
this hypothesis.
The experiment also allows validation of the prediction of
fast receptor internalization. The model predicts a recep-
tor complex internalization half-life of ln2/ki = 3.4min
and a very rapid decrease of the total non-internalized
receptor (Additional file 5). This nicely corresponds to the
experimental observation that more than half of the
receptor is internalized after 5 min (Figure 6A) and thus
presents another indication for the validity of the model.
Discussion
Tight regulation of NFκB by the negative feedback loop
involving post-degradational resynthesis of IκBα is man-
datory to ensure proper cellular function. Constitutive
NFκB activation is linked to transformation, proliferation,
suppression of apoptosis, and metastasis [1,26]. Thus,
strategies interfering with the signaling pathways activat-
ing NFκB have become major targets for anti-cancer inter-
ventions [27]. The negative feedback loop controlling
NFκB activity is critically regulated by the phosphoryla-
tion status of the upstream kinase IKKβ. Phosphorylation
of Ser 177/181 is a prerequisite for initial phosphoryla-
tion and degradation of IκBα. Vice versa, dephosphoryla-
tion of these IKKβ serine residues is required to prevent
phosphorylation of resynthesized IκBα being a prerequi-
site for NFκB termination [6]. Concerning the molecular
mechanism underlying UVB-induced abrogation of the
negative feedback loop, we have recently discovered Ser-
Thr-phosphatase PP2A to be crucially involved in tuning
the phosphorylation status of IKKβ. Impeding IκBα reap-
pearance upon co-stimulation with UVB was linked to
UVB-induced inhibition of PP2Ac, causing chronic IKKβ
phosphorylation followed by downstream phosphoryla-
tion and degradation of resynthesized IκBα [10]. Under-
standing the general PP2Ac/IKKβ cross talk at the IKK
complex, the mode of interference of UVB with PP2Ac
activity and the chronology of events leading to full abro-
gation of the negative feedback loop is of high importance
under therapeutic aspects.
Conflicting data about the contribution of PP2A in mod-
ulating NFκB activity exist, while most of the reports con-
nect inhibition of PP2A to NFκB activation [10,28-32].
Less evidence exists suggesting IKK-PP2A complex forma-
tion to be a prerequisite for TNF-induced phosphoryla-
tion of IKKβ and degradation of IκBα [33]. Developing a
new reduced mathematical model strictly relying on
experimental data, we could confirm the critical role of
PP2A in antagonizing IKKβ phosphorylation and conse-
quently NFκB activity. By this means we were able to
A sensitive IL-1 dose reveals PP2Ac to be constitutively active at the IKK complexFigure 4
A sensitive IL-1 dose reveals PP2Ac to be constitu-
tively active at the IKK complex. (A) Cells were left 
untreated or stimulated with decreasing doses of IL-1 for 15 
min as indicated. The status of the initial IκBα degradation 
was determined by Western-blot analysis. (B) Cells were left 
untreated or stimulated with a sensitive dose of 0.5 ng/ml as 
derived from (A) for the indicated time points. Initial phos-
phorylation status of IKKβ as well as degradation of IκBα 
was documented by Western-blot analysis. (C) Cells were 
transfected with scrambled siRNA or siRNA specifically 
knocking down PP2Ac. 48 h later, cells were stimulated with 
0.5 ng/ml IL-1 for the indicated time points, and phosphoryla-
tion status of IKKβ, degradation of IκBα and protein level of 
PP2Ac were analysed by Western-blot. In each analysis α-
tubulin served as loading control. IKKβ phosphorylation was 
quantified using Image Quant software. Pooled data of three 
independently performed experiments are summarised. One 
representative Western-blot analysis is shown as Additional 
file 4.
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Model parameters are very well identifiable and suggest indirect deactivation of PP2Ac by UVBFigure 5
Model parameters are very well identifiable and suggest indirect deactivation of PP2Ac by UVB. (A) The histo-
grams show the parameter values of the best 10% out of 4000 fits. The initial parameter values for these fits were obtained by 
randomly varying the parameter values of the reference scenario (Table 1) by up to 4 orders of magnitude, as described in the 
Methods section. (B) The model rejects the hypothesis of immediate UVB induced PP2Ac deactivation. Assuming kdp = 0 in 
case of UVB stimulation, the experimental data cannot be reproduced (χ2 = 72.05 + 37.78 = 109.83).
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BMC Systems Biology 2009, 3:71 http://www.biomedcentral.com/1752-0509/3/71unravel the most evident activation status of PP2A at the
IKK complex and to predict a mechanism underlying
UVB-induced PP2Ac inactivation:
In unstimulated cells PP2A is most likely associated with
the IKK complex in a constitutively active fashion, where
it presumably controls dephosphorylation of randomly
activated IKKβ. Accordingly, we propose the following
model of PP2A function at the IKK complex: In case of IL-
1 mediated IL-1 receptor activation, the initial signal
input causing IKKβ phosphorylation overrules constitu-
tive PP2A activity, resulting in a net shift towards increase
in phosphorylated, i.e. active, IKKβ species, which reach a
peak after approximately 15 min. At this time point, IκBα
degradation is completed, but the exogenous IL-1 signal is
already close to terminated due to rapid IL-1R internaliza-
tion. Continuing PP2A activity thus results in a reversion
of the IKKβ status towards an unphosphorylated, inactive
species, which subsequently allows accumulation of
resynthesized IκBα. In case of PP2Ac inhibition by co-
stimulation with UVB, however, the dephosphorylation
of IKKβ is strongly impaired, resulting in persistent degra-
dation of newly synthesized IκBα, thereby causing abro-
gation of the negative feedback loop. Persistent nuclear
NFκB activity then promotes pro-apoptotic instead of
anti-apoptotic responses under these specific conditions
[10].
A constitutive PP2A activity is also consistent with the elu-
sive IKK inactivation mechanism in the model of [18] and
may present a promising candidate for the yet unknown
fast IKK inactivation mechanism following TNFα stimula-
tion. We could substantially improve our previous mode-
ling approach for IL-1 induced IKK phosphorylation [19]
and now present a validated model with well identifiable
parameters that incorporates recent findings about the
IKK deactivation process. It is independent of the down-
stream processes and only contains processes strictly nec-
essary to describe the observed dynamics.
The present model structure contains several simplifying
assumptions. Particularly, neither hyperphosphorylation
nor constitutive protein synthesis and degradation are
included, in contrast to other models, e.g. [21]. As shown
in detail in Additional file 1, V, these simplifications are
consistent with biological considerations and further sup-
ported by the fact that a model including these extensions
does not perform better than the original model. This
finding does not refute the different model structure cho-
sen by Lipniacki et al. [21] but rather indicates that the
mechanism of IKKβ deactivation following IL-1 stimula-
tion may differ from that following TNFα stimulation.
Besides the validated predictions concerning the fast
receptor kinetics, the model predicted that deactivation of
PP2A located at the IKK following UVB radiation does not
occur directly through UVB modifications of PP2A. This
prediction is consistent with data from Barisic et al. [10],
where total cellular PP2Ac activity is decreased, but still
discernable following 2 h of UVB radiation. Although
direct inactivation by UVB-mediated destruction of aro-
matic amino acids in the catalytic centre of Tyr-phos-
phatases has been reported [34,35] this does not seem to
be the case for Ser/Thr-phosphatase PP2A. Accordingly,
indirect deactivation of PP2A by UVB is most likely facili-
tated by other mediators yet to be identified.
Conclusion
We developed a model of IKKβ phosphorylation with well
identifiable parameters that is independent of the down-
stream processes. This model can be used as a reliable
building block for the input of NFκB models investigating
the mechanisms associated with the persistent activation
of NFκB, which results in pro-apoptotic behavior when
combined with UVB and other DNA damaging agents
[9,10,36,37]. In contrast to the vast majority of mathe-
matical models for the NFκB signaling pathway, the
present model considers IKK phosphorylation independ-
ently of IκBα and NFκB. This decouples IKK phosphoryla-
tion kinetics from IκBα kinetics and allows for a
considerable reduction of the system order. The obtained
small model allows for reliable determination of biologi-
cal parameters such as IKKβ dephosphorylation half-life
or half-life of UVB induced PP2Ac deactivation, which are
often difficult to obtain experimentally. The simplifying
assumptions on which the model is based are supported
by biological and model-based reasoning as well as by the
good fits to the experimental data and model validation,
thus offering a comprehensive simplification potential for
future modelling of NFκB signalling. Furthermore, model
expansions are very easy to implement, due to the modu-
lar model structure which links different modules by sig-
nal flows only. These expansions could involve modeling
of the omitted proteins in the signaling cascade such as
IRAK or TRAF6 [38], or the system behavior for variable
UVB doses. For long term studies, constitutive protein
synthesis and degradation could be taken into account.
Model expansions might also be required for low IL-1
Table 2: 95%-confidence intervals of the parameters in the 
reference scenario
Variable 95%-confidence interval Unit
ka [5.0, 8.5] (μM·s)-1
ki [0.0025, 0.0042] s-1
kp [0.095, 0.095] s-1
kdp [0.00060, 0.0011] s-1
kuv [0.00016, 0.00032] s-1
IKKscale [0.78, 1.2] -
Confidence intervals were obtained by fitting to perturbed 
experimental data and determining the 2.5% and 97.5% quantiles of 
the resulting parameter sets, as described in the Methods section.Page 10 of 13
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signaling cascade could play a more prominent role.
Combining experimental and modeling approaches sheds
new light on the dynamics of IKKβ phosphorylation and
the understanding of the negative feedback loop regula-
tion of NFκB. With respect to tumor maintenance and
progression resulting from constitutive NFκB activation
[39,40], the specific cellular activation status of PP2A
should be considered by support of mathematical mod-
els, and may consequently help to elucidate alternative
therapeutic targets to fight individual cancers.
Methods
Cells and reagents
The human epithelial carcinoma cell line KB (ATCC) was
cultured in RPMI 1640, 10% FCS. Subconfluent cells were
stimulated in colorless medium with 2% FCS. UVB irradi-
ation (300 J/m2) was performed with TL12 fluorescent
bulbs (290–320 nm, Philips). Recombinant human IL-1β
(R&D Systems) was applied at 10 ng/ml and 0.5 ng/ml,
respectively, as indicated. PP2Ac knock down was facili-
tated by transfecting 6 × 105 cells with 50 pmol siRNA: 5'-
GAGGUUCGAUGUCCAGUUA-3' (MWG) using Lipo-
fectamine 2000 (Invitrogen) 48 h prior to stimulation.
Scrambled siRNA 5'-UAGAAUUAUUCCUCAACAG-3'
served as negative control.
Western-blot analysis
Cells were harvested via the hot lysis method. Briefly at
the indicated time points supernatants were aspirated and
adherent cells lysed by addition of 100 μl of hot (95°C)
laemmli buffer followed by sonication and incubation at
95°C for further 10 min. After centrifugation, superna-
tants were collected and 15 μl of each protein samples
subjected to 10–12% SDS-PAGE, blotted onto nitrocellu-
lose membranes and incubated with antibodies directed
against pSer177/181-IKKβ, IκBα and PP2Ac (16A6,
L35A5, 2038; Cell Signaling) respectively. Equal loading
was monitored by reprobing membranes with an anti-
body against α-tubulin (DM1A, Neomarkers) and HRP
conjugated secondary antibodies (Amersham, Bucking-
hamshire, UK). Bands were visualized applying chemilu-
minescence SuperSignal®detection system (PIERCE).
Relative IKK phosphorylation was quantified densitomet-
rically from Western Blots and normalized againstα-tubu-
lin levels using Image Quant™ software. An initial
phosphorylation level of 0 for unstimulated IKK was
assumed. Time series were scaled in a way that their mean
equaled one, subsequently pooled, and finally scaled in a
way that the mean maximal value of both pooled time
series equaled one.
FACS analysis
To monitor levels of membrane bound IL-1R, FACS anal-
ysis was performed utilizing 0.5 μg of an anti IL-1R mouse
IgG (551388, Becton Dickinson) in 100 μl PBS/1% BSA
per 5 × 105 cells and a goat anti mouse IgG conjugated to
FITC (F9137, Sigma). Cells were analyzed in an EPICS®
XL-MCL flow cytometer (Coulter, Miami, USA). Excita-
tion wavelength used for FITC was 488 nm. The emitted
green fluorescence (λmax 520 nm) was detected using (FL-
1) band pass filter. 20 000 cells were analysed for each
sample. Data analysis was performed using the WIN/MDI
2.8 software.
Phosphatase assay
Cells were lysed as described above. Endogenous PP2Ac
was immunoprecipitated using a specific antibody (PC
UVB does not alter IKKβ phosphorylation via delay of IL-1 recept r internalizationFigure 6
UVB does not alter IKKβ phosphorylation via delay of 
IL-1 receptor internalization. (A) Cells were left 
untreated or stimulated with IL-1 (10 ng/ml) alone or in com-
bination with UVB (300 J/m2) for the indicated time points. 
Subsequently, IL-1 receptor expression was analyzed by flow 
cytometry using an IL-1 receptor specific antibody compared 
to an isotype control of the secondary antibody (FITC). The 
mean fluorescence intensity (MnX) of three independently 
performed experiments of this control was set as 1. Recep-
tor expression levels were determined respectively and the 
MnX of three independently performed experiments com-
pared to FITC control is presented. Consequently, an MnX 
of 1 in the experiments represents a completely internalized 
or degraded receptor. (B) The hypothesis of receptor inter-
nalization leads to a considerably inferior fit quality (χ2 = 
24.77 + 25.35 = 50.12). The model largely diverges from the 
experimental data for the 30 min value following IL-1 stimula-
tion and systematically underestimates the last 5 data points 
following IL-1 + UVB stimulation.
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overnight. Immunoprecipitated PP2Ac was diluted in 74
μl phosphatase assay buffer (50 mM Tris/HCl, pH 7.0;
100 μM CaCl2) and incubated with 6 μl threonine phos-
phopeptide (final conc. 75 μM; Biomol) for 5 min at
30°C. 20 μl malachite green solution (Bio Assay Systems)
was added and absorption measured at different time
points at 650 nm. Phosphatase activity of un-irradiated
cells was determined to be 100%. As an assay standard a
serial dilution of 40 μM phosphate (Bio Assay Systems)
was used. Equal amounts of immunoprecipitated PP2Ac
were monitored by Western-blot analysis following the
phosphatase assay compared to cell lysate with a specific
anti PP2Ac antibody (2038, Cell Signaling).
Model Analysis
The MATLAB (The MathWorks) based software tool box
PottersWheel 1.6 [41] was used for the solution, optimi-
zation and analysis of the ordinary differential equation
system. The χ2 value was chosen as objective function,
with
where yi is data point i with standard deviation σi and y(ti;θ) is the model value at time point i for the parameter vec-
tor θ. Initial parameter values prior to the first optimiza-
tion were arbitrarily chosen as 0.05 for all parameters.
Minimization was performed using the FitBoost routine,
which combines a trust region and a simulated annealing
approach. Additionally, 4000 fits with the trust region
approach were performed, each starting from the parame-
ter values of the currently best fit randomly disturbed by
up to 4 orders of magnitude (pwF3 routine), thus covering
a range of 8 orders of magnitude.
In order to assess the reliability of the obtained best fit
parameters, we investigated whether they can be uniquely
determined for the given experimental data (identifiabil-
ity analysis) and how perturbations of the experimental
data within the measuring accuracy affect the parameter
estimation (confidence intervals).
Identifiability analysis was performed by conducting
4000 independent fits with the trust region method, each
starting from the parameter values of the best fit randomly
disturbed by up to 4 orders of magnitude (pwF2 routine).
The best 10% of the fits were selected for analysis. For esti-
mation of the confidence intervals, 500 new data sets were
generated by adding an N(0, σi2) distributed error term to
each data point of the original data, where σi is the exper-
imentally determined standard deviation at time point i.
Separate fitting was performed for each data set, using the
FitBoost routine. Additionally 200 fits were performed
with the pwF3 routine with random perturbations of up
to 2 orders of magnitude, in order to reduce the computa-
tional effort. The 2.5% and 97.5% quantiles of the result-
ing parameter sets were determined.
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Supplementary information about the modelling procedure. Includes a 
more detailed description of several aspects of the modelling procedure.
Click here for file
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Additional file 2
Simulation results of the reference model with different parameteri-
zation. The fit is slightly worse but visually more satisfactory than the ref-
erence scenario.
Click here for file
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Additional file 3
Simulation results for the alternative model with delayed PP2A acti-
vation. Shows the fit and describes the model equations of the alternative 
model.
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of total IL-1 receptor (ILR + ILRc) in the reference scenario.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-3-71-S5.pdf]Page 12 of 13
(page number not for citation purposes)
BMC Systems Biology 2009, 3:71 http://www.biomedcentral.com/1752-0509/3/71Acknowledgements
This work was supported by grants from the Deutsche Forschungsgesells-
chaft (DFGKU 1981/1-1). We thank Markus Koschorreck and Klaus Pfizen-
maier for inspiring discussions and critically reading the manuscript.
References
1. Aggarwal BB: Nuclear factor-kappaB: the enemy within.  Cancer
Cell 2004, 6:203-208.
2. Cortes SM, Rodriguez FV, Sanchez PI, Perona R: The role of the
NFkappaB signalling pathway in cancer.  Clin Transl Oncol 2008,
10:143-147.
3. Maeda S, Omata M: Inflammation and cancer: role of nuclear
factor-kappaB activation.  Cancer Sci 2008, 99:836-842.
4. Naugler WE, Karin M: NF-kappaB and cancer-identifying tar-
gets and mechanisms.  Curr Opin Genet Dev 2008, 18:19-26.
5. Karin M, Yamamoto Y, Wang QM: The IKK NF-kappa B system:
a treasure trove for drug development.  Nat Rev Drug Discov
2004, 3:17-26.
6. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative
regulation of IkappaB kinase activity through IKKbeta subu-
nit phosphorylation.  Science 1999, 284:309-313.
7. Kothny-Wilkes G, Kulms D, Poppelmann B, Luger TA, Kubin M,
Schwarz T: Interleukin-1 protects transformed keratinocytes
from tumor necrosis factor-related apoptosis-inducing lig-
and.  J Biol Chem 1998, 273:29247-29253.
8. Kothny-Wilkes G, Kulms D, Luger TA, Kubin M, Schwarz T: Inter-
leukin-1 protects transformed keratinocytes from tumor
necrosis factor-related apoptosis-inducing ligand- and CD95-
induced apoptosis but not from ultraviolet radiation-induced
apoptosis.  J Biol Chem 1999, 274:28916-28921.
9. Pöppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D:
NFκB-dependent down-regulation of tumor necrosis factor
receptor-associated proteins contributes to interleukin-1-
mediated enhancement of ultraviolet B-induced apoptosis.  J
Biol Chem 2005, 280:15635-15643.
10. Barisic S, Strozyk E, Peters N, Walczak H, Kulms D: Identification
of PP2A as a crucial regulator of the NF-kappaB feedback
loop: its inhibition by UVB turns NF-kappaB into a pro-apop-
totic factor.  Cell Death Differ 2008, 15:1681-1690.
11. Scott ML, Fujita T, Liou HC, Nolan GP, Baltimore D: The p65 sub-
unit of NF-kappa B regulates I kappa B by two distinct mech-
anisms.  Genes Dev 1993, 7:1266-1276.
12. Cheong R, Hoffmann A, Levchenko A: Understanding NF-kappaB
signaling via mathematical modeling.  Mol Syst Biol 2008, 4:192.
13. Hoffmann A, Levchenko A, Scott ML, Baltimore D: The IkappaB-
NF-kappaB signaling module: temporal control and selective
gene activation.  Science 2002, 298:1241-1245.
14. Hengl S, Kreutz C, Timmer J, Maiwald T: Data-based identifiability
analysis of non-linear dynamical models.  Bioinformatics 2007,
23:2612-2618.
15. Cho KH, Shin SY, Lee HW, Wolkenhauer O: Investigations into
the analysis and modeling of the TNF alpha-mediated NF-
kappa B-signaling pathway.  Genome Res 2003, 13:2413-2422.
16. Park SG, Lee T, Kang HY, Park K, Cho KH, Jung G: The influence
of the signal dynamics of activated form of IKK on NF-kap-
paB and anti-apoptotic gene expressions: a systems biology
approach.  FEBS Lett 2006, 580:822-830.
17. Werner SL, Barken D, Hoffmann A: Stimulus specificity of gene
expression programs determined by temporal control of
IKK activity.  Science 2005, 309:1857-1861.
18. Cheong R, Bergmann A, Werner SL, Regal J, Hoffmann A, Levchenko
A: Transient IkappaB kinase activity mediates temporal NF-
kappaB dynamics in response to a wide range of tumor
necrosis factor-alpha doses.  J Biol Chem 2006, 281:2945-2950.
19. Witt J, Husser S, Kulms D, Barisic S, Sawodny O, Sauter T: Modeling
of IL-1 induced NF-kappaB signaling and analysis of  ional
UVB influence.  SICE 2007 Annual Conference 2007, 1:1353-1358.
20. Heinrich R, Schuster S: The regulation of cellular systems 1st edition.
New York: Chapman & Hall; 1996. 
21. Lipniacki T, Paszek P, Brasier AR, Luxon B, Kimmel M: Mathemati-
cal model of NF-kappaB regulatory module.  J Theor Biol 2004,
228:195-215.
22. Krikos A, Laherty CD, Dixit VM: Transcriptional activation of
the tumor necrosis factor alpha-inducible zinc finger protein,
A20, is mediated by kappa B elements.  J Biol Chem 1992,
267:17971-17976.
23. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A: Fail-
ure to regulate TNF-induced NF-kappaB and cell death
responses in A20-deficient mice.  Science 2000, 289:2350-2354.
24. Qwarnstrom EE, Page RC, Gillis S, Dower SK: Binding, internaliza-
tion, and intracellular localization of interleukin-1 beta in
human diploid fibroblasts.  J Biol Chem 1988, 263:8261-8269.
25. Bonizzi G, Piette J, Merville MP, Bours V: Distinct signal transduc-
tion pathways mediate nuclear factor-kappaB induction by
IL-1beta in epithelial and lymphoid cells.  J Immunol 1997,
159:5264-5272.
26. Luque I, Gelinas C: Rel/NF-kappa B and I kappa B factors in
oncogenesis.  Semin Cancer Biol 1997, 8:103-111.
27. Lin A, Karin M: NF-kappaB in cancer: a marked target.  Semin
Cancer Biol 2003, 13:107-114.
28. Hong S, Wang LC, Gao X, Kuo YL, Liu B, Merling R, Kung HJ, Shih
HM, Giam CZ: Heptad repeats regulate protein phosphatase
2a recruitment to I-kappaB kinase gamma/NF-kappaB
essential modulator and are targeted by human T-lympho-
tropic virus type 1 tax.  J Biol Chem 2007, 282:12119-12126.
29. Palkowitsch L, Leidner J, Ghosh S, Marienfeld RB: Phosphorylation
of serine 68 in the IkappaB kinase (IKK)-binding domain of
NEMO interferes with the structure of the IKK complex and
tumor necrosis factor-alpha-induced NF-kappaB activity.  J
Biol Chem 2008, 283:76-86.
30. Sun SC, Maggirwar SB, Harhaj E: Activation of NF-kappa B by
phosphatase inhibitors involves the phosphorylation of I
kappa B alpha at phosphatase 2A-sensitive sites.  J Biol Chem
1995, 270:18347-18351.
31. Sung SJ, Walters JA: Stimulation of interleukin-1 alpha and
interleukin-1 beta production in human monocytes by pro-
tein phosphatase 1 and 2A inhibitors.  J Biol Chem 1993,
268:5802-5809.
32. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA:
Phosphorylation of human I kappa B-alpha on serines 32 and
36 controls I kappa B-alpha proteolysis and NF-kappa B acti-
vation in response to diverse stimuli.  EMBO J 1995,
14:2876-2883.
33. Kray AE, Carter RS, Pennington KN, Gomez RJ, Sanders LE, Llanes
JM, Khan WN, Ballard DW, Wadzinski BE: Positive regulation of
IkappaB kinase signaling by protein serine/threonine phos-
phatase 2A.  J Biol Chem 2005, 280:35974-35982.
34. Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P: Dephosphorylation
of receptor tyrosine kinases as target of regulation by radia-
tion, oxidants or alkylating agents.  EMBO J 1996, 15:5314-5325.
35. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H: Oxidation
state of the active-site cysteine in protein tyrosine phos-
phatase 1B.  Nature 2003, 423:773-777.
36. Campbell KJ, Rocha S, Perkins ND: Active repression of antiap-
optotic gene expression by RelA(p65) NF-kappa B.  Mol Cell
2004, 13:853-865.
37. Strozyk E, Poppelmann B, Schwarz T, Kulms D: Differential effects
of NF-kappaB on apoptosis induced by DNA-damaging
agents: the type of DNA damage determines the final out-
come.  Oncogene 2006, 25:6239-6251.
38. O'Neill LA, Greene C: Signal transduction pathways activated
by the IL-1 receptor family: ancient signaling machinery in
mammals, insects, and plants.  J Leukoc Biol 1998, 63:650-657.
39. Ahn KS, Sethi G, Aggarwal BB: Nuclear factor-kappa B: from
clone to clinic.  Curr Mol Med 2007, 7:619-637.
40. Sethi G, Sung B, Aggarwal BB: Nuclear factor-kappaB activation:
from bench to bedside.  Exp Biol Med (Maywood) 2008, 233:21-31.
41. Maiwald T, Timmer J: Dynamical modeling and multi-experi-
ment fitting with PottersWheel.  Bioinformatics 2008,
24:2037-2043.Page 13 of 13
(page number not for citation purposes)
